OXT and schizophrenia: These demonstrated a potential therapeutic effect of oxytocin through inhibiting presynaptic dopamine function, subsequently correcting the dopamine hyperactivity in the mesolimbic pathway, which contributes to the positive symptoms of schizophrenia, and counteracting the hypoglutamatergia profile [37].